Statins are highly effective drugs prescribed to millions of people to lower LDL-cholesterol
and decrease cardiovascular risk. The benefits of statin therapy seen in randomized clinical …

Racial and ethnic disparities in cardiovascular health care are well documented. Promising
approaches to disparity reduction are increasingly described in literature published since …

Abstract An Expert Panel convened by the National Lipid Association previously developed
a consensus set of recommendations for the patient-centered management of dyslipidemia …

Background: The associations of low-density lipoprotein cholesterol (LDL-C) with
cardiovascular disease (CVD) and coronary heart disease mortality in an exclusively low …

Background—No studies have comprehensively examined the prevalence of dyslipidemia,
a major risk factor for cardiovascular disease, among diverse racial/ethnic minority groups …

Objectives: This study aimed to evaluate the effectiveness of 3-hydroxy-3-methyl-glutaryl-
CoA reductase inhibitors (statins) in primary prevention of cardiovascular events …

Background Few data are available on the use of statins after publication of the National
Cholesterol Education Program Third Adult Treatment Panel (ATP-III) guidelines in 2001 …

Non‐alcoholic fatty liver disease (NAFLD) and cardiovascular disease are independently
associated. Due to the efficacy of 3‐hydroxy 3‐methylglutaryl‐coenzyme A reductase …

Importance Statins are not prescribed to approximately 50% of patients who could benefit
from them. Objective To evaluate the effectiveness of an automated patient dashboard using …

Purpose There has been growing interest in the potential anticancer activity of statins based
on preclinical evidence of their antiproliferative, proapoptotic, and radiosensitizing …